Deshpande Milind
Insider CIK 1378588 · ACHN President of R&D and CSO, Director · SPRO Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2026-06-23 | 2026-06-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award | 2026-06-23 | 2026-06-25 | 10,000 | — | $0 | 101,454 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award | 2025-06-12 | 2025-06-16 | 20,000 | — | $0 | 91,454 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award | 2024-05-29 | 2024-05-30 | 20,000 | — | $0 | 71,454 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award | 2023-10-05 | 2023-10-10 | 20,000 | — | $0 | 51,454 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award | 2022-09-15 | 2022-09-19 | 15,000 | — | $0 | 31,454 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2021-08-17 | 2021-08-18 | 7,500 | — | $0 | 7,500 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2021-01-04 | 2021-01-06 | 2,629 | $13.31 | $35.0K | 2,629 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2020-10-27 | 2020-10-27 | 7,500 | — | $0 | 7,500 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2020-01-02 | 2020-01-06 | 5,408 | $6.47 | $35.0K | 5,408 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2019-06-05 | 2019-06-05 | 6,073 | — | $0 | 6,073 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2018-06-05 | 2018-06-06 | 6,073 | — | $0 | 6,073 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | A Award deriv | 2018-02-09 | 2018-02-13 | 640,000 | — | $0 | 640,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | A Award deriv | 2017-01-17 | 2017-01-19 | 458,000 | — | $0 | 458,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | P Buy | 2016-12-02 | 2016-12-05 | 2,500 | $4.06 | $10.1K | 2,500 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | A Award deriv | 2016-01-20 | 2016-01-22 | 400,000 | — | $0 | 400,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise deriv | 2015-01-21 | 2015-01-23 | 100,000 | — | $0 | 300,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2015-01-21 | 2015-01-23 | 100,000 | $15.00 | $1.50M | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise | 2015-01-21 | 2015-01-23 | 100,000 | $3.02 | $302.0K | 100,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | A Award deriv | 2014-12-02 | 2014-12-04 | 345,000 | — | $0 | 345,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise deriv | 2014-08-18 | 2014-08-19 | 15,950 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise deriv | 2014-08-18 | 2014-08-19 | 60,000 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise deriv | 2014-08-18 | 2014-08-19 | 124,424 | — | $0 | 75,576 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise deriv | 2014-08-18 | 2014-08-19 | 16,250 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise | 2014-08-18 | 2014-08-19 | 124,424 | $3.10 | $385.7K | 124,424 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2014-08-18 | 2014-08-19 | 60,000 | $10.00 | $600.0K | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise | 2014-08-18 | 2014-08-19 | 60,000 | $3.28 | $196.8K | 60,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2014-08-18 | 2014-08-19 | 15,950 | $10.00 | $159.5K | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2014-08-18 | 2014-08-19 | 124,424 | $10.00 | $1.24M | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2014-08-18 | 2014-08-19 | 16,250 | $10.00 | $162.5K | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise | 2014-08-18 | 2014-08-19 | 16,250 | $4.00 | $65.0K | 16,250 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise | 2014-08-18 | 2014-08-19 | 15,950 | $1.05 | $16.7K | 15,950 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | J Other deriv | 2014-05-23 | 2014-05-23 | 250,000 | — | $0 | 150,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | A Award deriv | 2014-05-23 | 2014-05-23 | 250,000 | — | $0 | 400,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | A Award deriv | 2013-12-17 | 2013-12-19 | 400,000 | — | $0 | 400,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | A Award deriv | 2013-05-28 | 2013-05-30 | 600,000 | — | $0 | 600,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | A Award deriv | 2012-12-18 | 2012-12-20 | 145,000 | — | $0 | 145,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise deriv | 2012-03-15 | 2012-03-19 | 5,312 | — | $0 | 15,950 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2012-03-15 | 2012-03-19 | 5,312 | $10.70 | $56.8K | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise | 2012-03-15 | 2012-03-19 | 5,312 | $1.05 | $5.6K | 5,312 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise deriv | 2012-01-09 | 2012-01-11 | 10,625 | — | $0 | 21,262 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise | 2012-01-09 | 2012-01-11 | 10,625 | $1.05 | $11.2K | 10,625 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2012-01-09 | 2012-01-11 | 10,625 | $9.34 | $99.2K | 0 | SEC↗ |